Reducing the Duration of Untreated Psychosis in the United States (R34)

Funding Opportunity PAR-16-264 from the NIH Guide for Grants and Contracts. Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Compared to traditional treatment approaches, programs that integrate pharmacologic, psychological, and rehabilitation interventions for FEP, i.e., team-based Coordinated Specialty Care (CSC), have been found to produce a range of positive clinical and functional outcomes. However, the timing of treatment is critical; short and long-term outcomes are better when individuals begin treatment close to the onset of psychosis. Unfortunately, numerous studies find a substantial delay between the onset of psychotic symptoms and the initiation of FEP care; in the U.S. treatment is typically delayed between one and three years. Early identification of FEP, rapid referral to evidence-based services, and effective engagement in CSC are essential to shortening the duration of untreated psychosis (DUP) and pre-empting the functional deterioration common in psychotic disorders. The World Health Organization advocates reducing DUP to 3 months or less. Accordingly, this Funding Opportunity Announcement (FOA) seeks planning grant applications that (1) identif...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding

Related Links:

Source: Neuropsychiatric Disease and Treatment - Category: Psychiatry Tags: Neuropsychiatric Disease and Treatment Source Type: research
The company plans to use the funding to expand its capabilities  to identify more conditions incuding schizophrenia and multiple sclerosis. 
Source: mobihealthnews - Category: Information Technology Source Type: news
Programs ‌ ‌called‌ ‌assertive‌ ‌community‌ ‌treatment‌ ‌provide‌‌‌ ‌the‌ ‌kinds‌ ‌of‌ ‌services‌ ‌offered‌ ‌in‌ ‌psychiatric‌ ‌hospitals‌, ‌within‌ ‌a‌ ‌home‌ ‌setting.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Mental Health and Disorders Murders, Attempted Murders and Homicides Police Brutality, Misconduct and Shootings Prisons and Prisoners Psychiatry and Psychiatrists Schizophrenia Source Type: news
Women with schizophrenia are only half as likely as women in the general population to receive mammograms, reports ameta-analysis published inPsychiatric Services in Advance.“Lower screening rates could explain why women with schizophrenia and other serious mental illnesses are found to have more advanced breast cancer at time of diagnosis,” wrote Alison Hwong, M.D., Ph.D., and colleagues at the University of California, San Francisco. “Given the high prevalence o f breast cancer and the promising prognosis of breast cancer if detected early, mammography screening is a key first step in improving diagnosi...
Source: Psychiatr News - Category: Psychiatry Tags: Alison Hwong breast cancer cancer screening mammogram meta-analysis preventive service Psychiatric Services in Advance psychotic disorders schizophrenia Source Type: research
AbstractContinuing antipsychotic treatment in patients with schizophrenia under clinical remission remains controversial. Even though the mainstream opinion declares an outweighed balance against medication discontinuation, recent reviews and critiques suggest that some patients may remain symptom free and well functioning after stopping antipsychotics, but few predictors can identify who can try medication discontinuation, whilst no guidelines exist for reducing medication to reach the lowest effective dose safely. Analyzing the findings from studies employing different methodologies, adopting evidence from pharmacodynami...
Source: CNS Drugs - Category: Neurology Source Type: research
Source: Journal of Addictive Diseases - Category: Addiction Authors: Source Type: research
Translational Psychiatry, Published online: 18 November 2019; doi:10.1038/s41398-019-0643-yMitochondrial deficits in human iPSC-derived neurons from patients with 22q11.2 deletion syndrome and schizophrenia
Source: Translational Psychiatry - Category: Psychiatry Authors: Source Type: research
ConclusionsFirstly, variability in neurocognitive and imaging manifestations of B12 deficiency can limit delineation of other pathologies. Failure to improve following correction of nutritional deficiencies warrants further investigation for an alternate diagnosis. Secondly, re-evaluation of patients with comorbid mental health conditions is important in reaching timely and accurate diagnoses.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
Abstract Paliperidone palmitate is a second generation antipsychotic, approved for the treatment of schizophrenia in the form of the long-acting injectable (LAI) products INVEGA SUSTENNA® (once monthly injection) and INVEGA TRINZA® (once every 3 months injection). Paliperidone palmitate dissolves slowly after deep intramuscular injection before being hydrolyzed to paliperidone and absorbed into the systemic circulation. The pharmacokinetic (PK) profile of the INVEGA SUSTENNA® formulation is biphasic, comprised of an initial relatively fast zero-order input, which allows rapid attainment of therapeutic ...
Source: J Pharm Pharm Sci - Category: Drugs & Pharmacology Authors: Tags: J Pharm Pharm Sci Source Type: research
Many studies suggest that the hippocampus is involved in the pathophysiology of psychiatric disorders, especially major depressive disorder (MDD) and schizophrenia. Especially, in vivo imaging studies indicate that the volume of hippocampus may be reduced ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
More News: Contracts | Funding | Grants | Health | International Medicine & Public Health | Psychology | Rehabilitation | Research | Schizophrenia | Study | WHO